U.S., Dec. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07280234) titled 'Comparison of Intradermal Microinjections of Tanexamic Acid and Oral Tranexamic Acid in the Management of Melasma.' on Nov. 28.

Brief Summary: In this study we compared the effect of intradermal microinjections of tranexamic acid vs oral tranexamic acid in treatment of melasma. Given the high prevalence of melasma in Pakistan and the significant psychosocial impact on patients, particularly in Peshawar, this study will provide valuable insights into optimal treatment strategies

Study Start Date: Nov. 14, 2024

Study Type: INTERVENTIONAL

Condition: Melasma

Intervention: DRUG: Intradermal microinjections of tranexamic acid

This ...